###begin article-title 0
###xml 77 85 <span type="species:ncbi:9606">Patients</span>
Comparison of C-Reactive Protein and Serum Amyloid A Protein in Septic Shock Patients
###end article-title 0
###begin p 1
Recommended by Freek Zijlstra
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 205 213 <span type="species:ncbi:9606">patients</span>
###xml 235 243 <span type="species:ncbi:9606">patients</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
Septic shock is a severe inflammatory state caused by an infectious agent. Our purpose was to investigate serum amyloid A (SAA) protein and C-reactive protein (CRP) as inflammatory markers of septic shock patients. Here we evaluate 29 patients in postoperative period, with septic shock, in a prospective study developed in a surgical intensive care unit. All eligible patients were monitored over a 7-day period by sequential organ failure assessment (SOFA) score, daily CRP, SAA, and lactate measurements. CRP and SAA strongly correlated up to the fifth day of observation but were not good predictors of mortality in septic shock.
###end p 3
###begin title 4
1. INTRODUCTION
###end title 4
###begin p 5
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Severe sepsis and septic shocks are a common cause of mortality in intensive care unit (ICU) [1]. They are a state of systemic inflammation in response to infectious agents that can lead to multiple organ system failure and death.
###end p 5
###begin p 6
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 920 921 920 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 732 740 <span type="species:ncbi:9606">patients</span>
The systemic inflammatory response to infection involves the release of several mediators, which has led to the suggestion that some of these mediators could be used as markers of sepsis severity [2]. Among the acute-phase proteins that participate in the inflammatory response, C-reactive protein (CRP) is a component of the innate immune system that binds phosphocoline and recognizes some foreign pathogens as well as phospholipid constituents of damage cells; serum amyloid A (SAA) protein is an apolipoprotein that rapidly binds to high-density lipoprotein after their synthesis, influencing cholesterol metabolism during inflammatory states, causing adhesion and chemotaxis of phagocitic cells and lymphocytes [3, 4]. In some patients with chronic inflammation, the net effect of increased SAA production may be deleterious due to tissue deposition of its fragments and the development of systemic amyloidosis [3, 5].
###end p 6
###begin p 7
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 978 979 978 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 534 540 <span type="species:ncbi:9606">humans</span>
CRP and SAA display a similar pattern in most inflammatory diseases, reaching a maximum serum concentration about 24 hours after the inflammatory process sets in and slowly decreasing [6]. CRP is commonly used as a marker of an acute inflammatory state, produced by the liver in response to tissue injury or infection [7]. Its plasma concentration has been reported to parallel the clinical course of infection and the fall of the protein level indicates the resolution of infection [1]. SAA is the other major acute-phase protein in humans, with the earliest and highest increase rate of all acute-phase proteins, including CRP [4, 8]. SAA concentrations usually parallel those of CRP. Some authors have been reported that SAA appears to be a clinically useful marker of inflammation in bacterial or viral infection likewise CRP [9]. Although some studies suggest that SAA is a more sensitive marker of inflammatory disease, assays for SAA are not widely available at present [4].
###end p 7
###begin p 8
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
Until now, no study has compared daily CRP to SAA plasma concentrations in postoperative patients with septic shock, or has correlated them to the severity of patients represented by SOFA score. This study aimed to evaluate CRP and SAA measurements as markers of severity of septic shock patients during postoperative period.
###end p 8
###begin title 9
2. METHODS
###end title 9
###begin p 10
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 125 133 <span type="species:ncbi:9606">patients</span>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
###xml 442 450 <span type="species:ncbi:9606">Patients</span>
###xml 672 680 <span type="species:ncbi:9606">Patients</span>
This study was prospective at a surgical ICU. After approval by a local ethics committee, informed consent was obtained from patients or from their next of kin prior to enrollment [10]. Twenty-nine patients admitted into the surgical ICU of the Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo had taken part in the study. Additional three patients were excluded after their next of kin gave up the signed consent. Patients with septic shock diagnosed during ICU stay were eligible for the study. We used the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definition of sepsis and septic shock [11]. Patients under 18 were excluded.
###end p 10
###begin p 11
###xml 62 111 62 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">acute physiology and chronic health evaluation II</italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 198 233 198 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sequential organ failure assessment</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 136 144 <span type="species:ncbi:9606">Patients</span>
Severity of illness at the baseline was assessed based on the acute physiology and chronic health evaluation II (APACHE II) score [12]. Patients were assessed daily for 7 consecutive days using the sequential organ failure assessment score (SOFA) or until their discharge from the ICU when occurring in less than 7 days [13-15]. C-reactive protein and serum amyloid A protein were also measured daily.
###end p 11
###begin p 12
###xml 4 12 <span type="species:ncbi:9606">patients</span>
The patients received conventional therapy regarding antibiotic regimens, serial blood cultures (whenever that body temperature >38degreesC), and discharge criteria. Relevant clinical and laboratory tests were conducted daily throughout the study.
###end p 12
###begin p 13
Blood samples for CRP and SAA dosage were thawed and assayed in batches in an automated analyzer (Behring Nephelometer Analyzer II, Dade Behring, Marburg, Denmark) for particle-enhanced immunonephelometry using commercial kits. The analytical sensitivity and accuracy for CRP was 0.0175 mg/L (coefficient of variation (CV) 7,6%). The analytical sensitivity and accuracy for SAA was determined by the lower limit of the reference curve and thus depended on the concentration of the protein in SAA standard test (CV between 5.4% and 6.4%).
###end p 13
###begin p 14
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical analysis was performed using commercial available package. Multiple logistic regressions were performed to test mortality of 7 or 28 days follow-up. A distribution analysis was made by the Kolmogorov-Smirnov test, Pearson correlation coefficients were determined, and repeated measures were tested by ANOVA. A P value < .05 was considered significant.
###end p 14
###begin title 15
3. RESULTS
###end title 15
###begin p 16
###xml 197 204 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 207 214 201 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 170 178 <span type="species:ncbi:9606">patients</span>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
The mean (+/-SD) age of the 29 patients was 65 +/- 13.9 years (range, 34 to 88 years). The study involved 13 males and 16 females (45%/55%). The APACHE II score of these patients was 19.8 +/- 4.5 (Table 1). Table 2 represents the microbiological characteristics of the studied patients.
###end p 16
###begin p 17
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 159 160 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 266 273 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
SOFA did not show increase from Day 0 to Day 7 of observation (P = .589, ANOVA) while CRP reduced significantly from Day 0 till the end of observation period (P < .001, ANOVA followed by Holm-Sidak test) as well as SAA (P < .001, ANOVA followed by Holm-Sidak test) (Table 3).
###end p 17
###begin p 18
CRP and SAA concentrations did not present any correlation with SOFA.
###end p 18
###begin p 19
###xml 84 91 84 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab4">Table 4</xref>
On the other hand, CRP and SAA have shown a good correlation from Day 0 till Day 5 (Table 4).
###end p 19
###begin p 20
###xml 165 172 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab5">Table 5</xref>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
Mortality of these patients in 7 days was 44.8% (13 in 29) and in 28 days was 65.5% (19 in 29). CRP and SAA concentrations were not associated with Day 7 mortality (Table 5).
###end p 20
###begin p 21
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2</xref>
CRP and SAA concentrations evolution during the first week comparing survivors and nonsurvivors were not statistically significant (Figures 1 and 2).
###end p 21
###begin title 22
4. DISCUSSION
###end title 22
###begin p 23
###xml 110 118 <span type="species:ncbi:9606">patients</span>
The present study revealed significant positive correlation between SAA and CRP in postoperative septic shock patients. SOFA or APACHE II did not correlate with those serum measurements. Neither marker nor index was associated with mortality rate.
###end p 23
###begin p 24
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
SAA has been considered by some authors to be equivalent to CRP in patients with bacterial infectious diseases in clinical practice [16]. Other authors suggest that SAA is a more sensitive marker than CRP in infections with low inflammatory activity (including many viral infections) and in other clinical conditions, especially those involving the lung tissue [16, 17]. Yet other studies have confirmed the role of SAA and CRP in diagnosis and management of neonatal infections [2, 18].
###end p 24
###begin p 25
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 486 494 <span type="species:ncbi:9606">patients</span>
###xml 984 992 <span type="species:ncbi:9606">patients</span>
The patterns of cytokine production and the acute-phase response differ for different inflammatory conditions. Acute-phase changes reflect the presence and intensity of inflammation and they have long been used as a clinical guide for diagnosis and management. Among patients with plasma CRP concentrations higher than 10 mg/dL, 80-to-85 percent have bacterial infections [4, 19]. In our study, all the patients were in septic shock with documented infection. We could observe that all patients during the 7-day period of observation presented plasma CRP concentrations greater than 10 mg/dL, according to results that Gabay et al. in a review article cited [4]. This fact could indicate that sepsis is secondary to bacterial infections. In relation to plasma SAA concentrations, a cutoff value has not been determined from previous studies. We observed a level higher or closer to 20 mg/dL, but more studies were needed to find a cutoff value for SAA as an early diagnostic tool for patients with infection.
###end p 25
###begin p 26
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
We did not observe difference between CRP and SAA early (Day 1) concentrations in patients who survived compared with those who died. Other authors have found that these proteins were not prognostic markers in patients with septic shock [7, 19]. This fact is in concordance with our results.
###end p 26
###begin p 27
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Previous reports have observed that CRP level was associated with organ failure in critically ill patients, although not specifically under septic shock [14]. This study could not find any good correlation between CRP or SAA with SOFA, probably not in agreement with other authors [20]. They believe that both CRP and SAA are good markers of organ dysfunction, considering the established diagnostic of septic shock.
###end p 27
###begin p 28
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 169 176 <span type="species:ncbi:9606">patient</span>
Study limitations are attributed primarily to the small sample size and the age of the patients that could influence CRP levels. Some authors believe that the older the patient is, the higher CRP levels that can be observed [21].
###end p 28
###begin p 29
In conclusion, SAA protein and CRP are strongly correlated, but were not good predictors of organ dysfunction and mortality in septic shock.
###end p 29
###begin article-title 30
Comparison of procalcitonin and C-reactive protein as markers of sepsis
###end article-title 30
###begin article-title 31
###xml 145 153 <span type="species:ncbi:9606">children</span>
Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children
###end article-title 31
###begin article-title 32
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human serum amyloid A has cytokine-like properties
###end article-title 32
###begin article-title 33
Acute-phase proteins and other systemic responses to inflammation
###end article-title 33
###begin article-title 34
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states
###end article-title 34
###begin article-title 35
###xml 93 98 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 113 117 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery
###end article-title 35
###begin article-title 36
Procalcitonin used as a marker of infection in the intensive care unit
###end article-title 36
###begin article-title 37
###xml 89 96 <span type="species:ncbi:9606">infants</span>
Serum amyloid A protein in the early detection of late-onset bacterial sepsis in preterm infants
###end article-title 37
###begin article-title 38
Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases
###end article-title 38
###begin article-title 39
Consent for observational studies in critical care: time to open Pandora's Box
###end article-title 39
###begin article-title 40
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
###end article-title 40
###begin article-title 41
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables
###end article-title 41
###begin article-title 42
###xml 87 95 <span type="species:ncbi:9606">patients</span>
C-reactive protein levels correlate with mortality and organ failure in critically ill patients
###end article-title 42
###begin article-title 43
Measures, markers, and mediators: toward a staging system for clinical sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000
###end article-title 43
###begin article-title 44
Correlations between serum amyloid A protein and C-reactive protein in infectious diseases
###end article-title 44
###begin article-title 45
###xml 59 67 <span type="species:ncbi:9606">children</span>
Correlation between the severity of infectious diseases in children and the ratio of serum amyloid A protein and C-reactive protein
###end article-title 45
###begin article-title 46
C-reactive protein and serum amyloid A protein in neonatal infections
###end article-title 46
###begin article-title 47
Procalcitonin: a valuable indicator of infection in a medical ICU?
###end article-title 47
###begin article-title 48
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction
###end article-title 48
###begin article-title 49
The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration
###end article-title 49
###begin p 50
CRP evolution of survivors and nonsurvivors during the first week (NS). NS: not statistically significant.
###end p 50
###begin p 51
SAA evolution of survivors and nonsurvivors during the first week (NS). NS: not statistically significant.
###end p 51
###begin p 52
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Baseline characteristics of the patients.
###end p 52
###begin p 53
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APACHE</italic>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOFA</italic>
APACHE: acute physiology and chronic health evaluation, SOFA: sequential organ failure assessment, COPD: chronic obstructive pulmonary disease.
###end p 53
###begin p 54
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Microbiological characteristics of patients.
###end p 54
###begin p 55
###xml 63 72 <span type="species:ncbi:1280">S. aureus</span>
###xml 74 95 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 97 108 <span type="species:ncbi:1314">S. pyogenes</span>
###xml 110 132 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
###xml 134 147 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 149 171 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 173 184 <span type="species:ncbi:1351">E. faecalis</span>
###xml 209 222 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 224 245 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 260 282 <span type="species:ncbi:470">Acinetobacter baumanii</span>
###xml 337 347 <span type="species:ncbi:550">E. cloacae</span>
###xml 349 369 <span type="species:ncbi:550">Enterobacter cloacae</span>
Vanco: vancomycin, Cipro: ciprofloxacin, Metro: metronidazole, S. aureus: Staphylococcus aureus, S. pyogenes: Streptococcus pyogenes, P. aeruginosa: Pseudomonas aeruginosa, E. faecalis: Enterobacter faecalis, K. pneumoniae: Klebsiella pneumoniae, A. baumanii: Acinetobacter baumanii, S. coag negative: Staphylococcus coagulase negative, E. cloacae: Enterobacter cloacae, BAL: bronchoalveolar lavage.
###end p 55
###begin p 56
SOFA, CRP, and SAA during the study period (mean +/- SD).
###end p 56
###begin p 57
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
SOFA: sequential organ failure assessment, CRP: C-reactive protein, SAA: serum amyloid A. ANOVA. Equal variance test: SOFA P = .956, CRP P = .062, SAA P = .055.
###end p 57
###begin p 58
Pearson coefficient for SAA and CPR.
###end p 58
###begin p 59
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Maximum likelihood, Wald statistic (P-value).
###end p 59

